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3Background. Limited evidence is available on a gene-environmental interaction of 
angiotensin-converting enzyme (ACE) gene I/D polymorphism and high blood pressure with 
salt intake among general populations. We hypothesized that persons with the I allele of ACE
gene have elevated blood pressure levels in response to a higher sodium intake, and thus the 
association of ACE I/D polymorphism with blood pressure levels was stronger among 
persons with a higher sodium intake than those with a lower sodium intake.
Methods. We conducted a population-based cross-sectional study of 2,823 men and women 
aged 30-74 years in a Japanese rural community to examine the association of the ACE I/D 
polymorphism with blood pressure levels stratified by salt intake, as estimated by 24-hour 
urine collection and dietary questionnaire. Polymorphism of the ACE I/D was detected by an 
allele-specific polymerase chain reaction. 
Results. There was no significant difference in blood pressure levels among DD, ID and II 
groups for either sex or total samples. However, mean difference in diastolic blood pressure 
levels for II vs DD groups was +3.0mmHg (p=0.003) among persons with higher sodium 
excretion, +1.8mmHg (p=0.04) among those with higher present sodium intake score, and 
+1.7mmHg (p=0.06) among those with higher past sodium intake score.
Conclusion. A high sodium intake strengthens the association of ACE I/D polymorphism 
with blood pressure levels in community-based samples. (220 words)
Key words: ACE, genetics, molecular epidemiology, salt sensitivity, gene-environment 
interaction, hypertension, sodium excretion, renin-angiotensin system
4INTRODUCTION
Angiotensin-converting enzyme (ACE) I/D polymorphism is a polymorphism of either 
presence or absence of 287 base-pair DNA fragment in intron 16 of ACE gene.1 Genetic 
associations between polymorphism of the ACE I/D and high blood pressure (BP) have been 
examined extensively, but findings on the association have been inconsistent. Some studies2-4, 
but not all5-7, reported that the D allele was responsible for elevation of BP while other 
clinical studies showed that I allele, but not D allele, was associated with hypertension.8,9 As 
for salt-sensitive hypertension, two clinical studies10-12 found a significant association with I 
allele; one study13 showed an association with D allele; and three studies14-16 showed no 
association. However, no population-based study was conducted for the association between 
I/D polymorphism and salt-sensitive hypertension, probably due to difficulty in the 
identification of salt-sensitive hypertension in community-based samples.
The aim of this study is to clarify the effect of sodium intake on association between 
ACE I/D polymorphism and BP among free-living community population. We hypothesized a 
priori that persons with the I allele of ACE gene elevated BP levels in response to higher 
sodium intake, and thus the association between I/D polymorphism and BP was stronger 
among persons with a higher sodium intake than those with a lower sodium intake. To 
examine the potential gene-environmental interaction, we conducted a large 
community-based observational study of 2,823 Japanese men and women. 
5METHODS
Study Population
Study population we used was similar to that of our previous reports.17,18 Briefly, we recruited 
the subjects from a farming rural community of Kyowa, Ibaraki prefecture, central Japan 
(census population in 2000: n=17,145) where annual cardiovascular risk surveys have been 
conducted since 1981. We included in the present study individuals who were aged 30-74 
years and participated in the 2001 survey (n=2,972). Physician epidemiologists explained the 
protocol to all participants, and obtained written informed consent from 95% (n=2,823) of 
them. The data of these 2,823 persons were used in the analysis. The study protocol was 
approved by the Medical Ethics Committee of the University of Tsukuba.
Well-trained BP observers measured arterial systolic blood pressure (SBP) and 
fifth-phase diastolic blood pressure (DBP) using standard mercury sphygmomanometers 
(with 14cm width and 51cm length cuff) on the right arm of quietly seated participants after 
at least five-minute rest. When the first SBP reading was ≥140 mmHg and/or DBP 
≥90mmHg, the measurement was repeated; the average of first and second readings was used 
in the analyses, and otherwise the first reading was used. We measured several potential 
confounders: body mass index (BMI), alcohol intake, urinary sodium and potassium 
excretion estimated by 24-hour urine collection, and past and present sodium intake scores 
estimated by self-administered questionnaire. 
All participants in the survey were asked to complete self-administered questionnaire 
to estimate both present and past habitual sodium intake. Past sodium intake was defined as 
the intake before the recognition of hypertension for hypertensives, and approximately 10 
years before the survey for normotensives. A sodium intake score was calculated by adding 
one point for each of 10 types of sodium intake: 1) prefer salty-food, 2) use salty seasoning, 
3) eat two or more miso soup servings per day, 4) eat pickles twice or more times per day, 5)
6eat salty pickles, 6) put soy sauce on pickles, 7) put soy sauce on meal, 8) eat salt-preserved 
food one or more times per week, 9) eat salty noodle soup, and 10) do not try to reduce salt 
intake. This scoring system was previously validated18-20, and again tested in the present study.
Age and sex-adjusted mean 24-hour sodium excretion values across quintiles of the present 
sodium intake score (n = 1,913) were 168, 183, 193, 201 and 202 mmol/L (p for trend < 
0.001). Repeatability of the present and past sodium intake scores was also tested 
previously17,20 by repeating the questionnaire one to two years apart for a sub-sample (n = 
287); the Spearman correlation coefficient was 0.73 for the present sodium intake score 
(p<0.001), and 0.62 for the past sodium intake score (p<0.001).17 In the present study, 99% of 
the subjects completed sodium intake questionnaire.  
To estimate salt intake more accurately, some participants collected one 24-hour 
urine sample, as previously reported.17,18 Urine samplings with lower than 500 ml or those 
with incomplete collections based on the records were excluded from the analyses. We 
included in the analyses a total of 1,920 subjects who completed the 24-hour urine collection 
between 1982 and 2005. 
DNA genotyping
ACE I/D genotypes were determined by allele-specific primer-polymerase chain reaction 
(PCR) method using Taq DNA polymerase (rTaq ; Toyobo, Osaka, Japan), as described 
elsewhere.21,22 The designed allele-specific sense primers were 
FITC-CTCGATCTCCTGACCTCGTGATCC for the D allele and 
TxR-CCTGCTGCCTATACAGTCACTTTTATG for the I allele labeled at the 5' end either 
with fluorescein isothiocyanate (FITC) or with Texas red (TxR), and a 5’ biotin-end-labeled
antisense primer (biotin-GATGTGGCCATCACATTCGTCAGAT).
7Statistical analyses
Analysis of covariance and chi-square tests were used to compare sex-specific age-adjusted 
mean values and proportions of risk characteristics according to the ACE I/D genotypes with 
the Tukey’s multiple comparison methods. The chi-square test was used to examine whether 
the genotype distributions differed from that expected from Hardy-Weinberg equilibrium.
The relationship between genotype and BP levels was examined by the analysis of covariance, 
adjusted for age, sex, antihypertensive medication use, body mass index, and alcohol intake. 
The statistical testing for BP differences between the genotypes DD and ID or II was 
conducted using the Dunnett’s multiple comparison methods, stratified by the medians of 
urinary sodium excretion, and present and past sodium intake score. For the analysis stratified 
by urinary sodium excretion, survey years of 24-hour urine collection (1982-1986, 1989-1993, 
1994-1997, 1998-2001, 2002-2005) were also adjusted. The interactions between genotype 
and sex, stratified sodium variables in relation to BP levels were examined using 
cross-product terms of these variables, i.e., polymorphism (DD, ID, II)  sex (M or F), 
polymorphism  sodium intake/excretion (below or beyond the median value). The hereditary 
mode was tested by multiple regression models, assigning DD=0 and ID or II=1 for dominant 
mode; DD or ID=0 and II=1 for recessive mode; and DD=0, ID=1 and II=2 for additive mode. 
All statistical analyses were performed using SAS version 9.1.3 (SAS Institute Inc.). All p 
value for statistical tests were two-tailed, and p<0.05 was regarded as statistical significance. 
8RESULTS
The frequency of ACE genotypes was 12.3% for DD genotypes, 45.4% for ID genotype, and 
42.3% for II genotype. The genotype distribution was in Hardy-Weinberg equilibrium for 
men (p=1.00), women (p=0.99) and total samples (p=1.00). Table 1 summarizes sex-specific 
clinical and laboratory characteristics. Mean age was 59 years for men and 57 years for 
women. The prevalence of hypertension was 48% for men and 38% for women, and mean 
24-hour urine sodium excretion was 205mmol and 179mmol, respectively. 
Table 2 provides sex-specific age-adjusted characteristics according to the genotype. 
For each sex and total samples, mean age did not vary among DD, ID and II groups. Either 
mean SBP or DBP levels was not different among three groups. Also, the prevalence of 
antihypertensive medication use and prevalence of hypertension did not differ among three 
groups. The other factors, i.e. BMI, alcohol intake, urine sodium excretion, past and present 
sodium intake score did not vary among three groups. 
Mean values of BP levels adjusting for sex, age, antihypertensive medication use, 
BMI, and alcohol consumption among ACE genotypes are shown in Table 3. There was no 
significant difference in BP levels between DD, ID and II groups for each sex and total 
samples. However, among subjects with higher sodium excretion, mean diastolic BP was 
higher in those with ID genotype (+3.0mmHg, p=0.003) and II genotype (+3.0mmHg, 
p=0.003) than in those with DD genotype for total subjects, but not among those with lower 
sodium excretion (p=0.02 for interaction). Among subjects with higher sodium excretion, the 
hereditary mode was statistically significant for dominant mode (p<0.001) and additive mode 
(p=0.01), but not for recessive mode (p=0.26).  
Among subjects with higher present sodium intake, mean DBP levels was higher in 
ID and II groups compared with DD group for total subjects (+1.7mmHg, p=0.05 and 
+1.8mmHg, p=0.04, respectively), but not for those with lower present sodium intake; 
9however the interaction did not reach statistical significance (p=0.17). Among subjects with 
higher present sodium intake, the p-values for hereditary mode were 0.02 for dominant, 0.37 
for recessive, and 0.07 for additive modes. Correspondingly, among subjects with higher past 
sodium intake, mean DBP levels tended to be higher in ID and II group compared with DD 
group for total subjects (+1.6 mmHg, p=0.06, and +1.7mmHg, p=0.06, respectively), but not 
for those with lower present sodium intake albeit insignificant interaction (p=0.24). Among 
subjects with higher past sodium intake, the hereditary mode were 0.03 for dominant, 0.46 for 
recessive, and 0.10 for additive modes. These trends among subgroups of each high sodium 
variables were similarly observed between men and women (sex interaction p=0.19 for 
higher sodium excretion, p=0.84 and 0.98 for higher present and past sodium intake, 
respectively), although these trends for each sex did not reach statistical significance 
probably due to the small number of DD subjects.
These results did not alter materially when restricting subjects without 
antihypertensive medication (n=2,196); mean DBP in II groups vs DD groups were 77.7 vs 
77.3 mmHg (p=0.79) for total samples, 78.0 vs 75.3 mmHg (p=0.02) for persons with higher 
sodium excretion, 77.5 vs 76.1 mmHg (p=0.17) for persons with higher present sodium 
intake score, and 77.5 vs 76.3 mmHg (p=0.24) for persons with higher past sodium intake 
score (data not shown).
When we used first readings of BP for the analyses, the results did not alter 
materially. Also, when we used mean values of BP measured in 2001 and 2000 surveys for a 
subsample (n=2,287), the results did not change materially. Moreover, when we used urine 
samples collected within five-years from 2001 survey (i.e. 1996-2005, n=1,549), the results 
were essentially same as shown in Table 3.
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DISCUSSION
In this large community-based association study, there was no significant difference in BP 
levels among DD, ID and II groups for either sex or total samples. However, we observed 
significant associations between I allele and elevated BP levels among persons with higher 
sodium excretion and higher past or present sodium intake scores, as we hypothesized a 
priori. Two previous studies revealed a positive association between I allele and 
salt-sensitivity among hypertensives. A study of 66 Japanese hypertensives showed that the 
prevalence of I allele was 77% among salt-sensitive hypertensives, whereas that of D allele 
was 55% among salt-resistant hypertensives.10 Another study of 48 Spanish hypertensives 
showed that patients with II genotype had elevated 24-hour BP after higher salt diet period 
compared with after lower salt diet period (+9.8mmHg for SBP and +5.2 for DBP), whereas 
patients with DD genotype showed smaller changes (+1.2mmHg for SBP and –0.2mmHg for 
DBP)11, which was confirmed by their subsequent study of larger samples (n=71).12 Recently, 
a cross-sectional study of 284 Japanese male workers showed a positive association between 
salt intake estimated by food frequency questionnaire and the proportion of hypertension 
among men with ACE I allele (39% for men with the highest tertile (≥10.78 g/day) salt intake
vs 19% for those with lowest tertile (≤8.15 g/day)), but not among those without it.23 Also, 
the European Project on Genes in Hypertension (EPOGH), a recent large family and 
population-based collaborative study, showed that the left ventricular mass was higher in II 
genotype than in ID+DD genotype among Slavic offsprings with higher sodium excretion, 
but not among those with lower sodium excretion.24 The present study extended evidence that 
sodium intake modifies the association of ACE I/D polymorphism with BP in a large 
free-living population.
We used large free-living community-based samples, which was the strength of the 
present study. Furthermore, we obtained sodium intake scores for 99% of subjects and 
11
24-hour urine collection samples for 68% of subjects, which allowed us to test 
gene-environmental interactions of ACE I/D polymorphism with BP levels. As for I/D 
polymorphism, no previous association study estimated the relationship between salt intake 
and BP or hypertension in a community-based samples, and the number of subjects on the 
previous studies of salt-related hypertension was approximately 30-30023,25, which was 
one-sixth or less of the present study. 
The present study has the several limitations. First, we used only single BP 
measurement in the analyses so that measurement variability may have weakened the genetic 
associations. However, since the number of the study subjects was large, we attained enough 
statistical power to detect gene-BP associations. When we used the first reading of BP, or 
means of BP data measured in 2000 and 2001 surveys, the results did not alter materially. 
Second, approximately 20% of subjects used antihypertensive medication which may obscure 
the genetic effect on BP levels. However, since the prevalence of antihypertensive medication 
use did not differ among the genotypes, this is unlikely. Third, we did not have the individual 
information which kind of drugs had been prescribed to the subjects for antihypertensive 
medication. Some antihypertensive drugs may modify the gene-BP association. However in 
this community, the majority of hypertensive patients seem to be treated primarily by calcium 
channel blockade like in other communities of Japan. Furthermore, the exclusion of persons 
on antihypertensive medication did not materially alter the genetic associations. Fourth, the 
variation of sodium excretion by one 24-h urine sample may be large and the 
misclassification between low and high sodium excretion groups is inevitable during a long 
sampling term. In the present study, however, 66% of persons remained in the same group of 
higher or lower sodium intake estimated from 24-h urine collection conducted within 5 years. 
Therefore, since our study had a large sample size, the impact of misclassification across the 
stratification is probably small. Fifth, a large time distance between BP measurement and 
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urine collection at most 19 years would make the interpretation for the results difficult. 
However, when we restricted the urine data of 2001±5 years (i.e. 1996-2005), the results did 
not alter materially. Last, BP levels were sometimes lower in groups of higher sodium
excretion or intake than in those of the lower ones in each genotype. A plausible reason for 
this phenomenon is that most of the hypertensive persons attempt to reduce sodium intake 
when they recognized their blood pressure levels were high, since sodium modification has 
been the most common strategy for prevention and control of hypertension in Japanese 
society.26
The present study showed that differences in mean value of DBP between DD and II 
groups was 2-3mmHg for persons with higher salt intake, which seemed to be small from a 
viewpoint of clinical practice. However, meta-analyses of nine prospective observational 
studies demonstrated that a long-term difference of 5mmHg in mean DBP was associated 
with 34% less stroke and 21% less coronary heart disease.27 Therefore, our finding, taken 
together with the results from the meta-analyses, was consistent with the possibility that salt 
reduction for persons with ACE I allele may have a substantial impact on prevention of 
cardiovascular disease.
In conclusion, ACE I allele was associated with higher DBP levels in persons with a 
higher sodium intake. The present study supports the hypothesis that ACE I allele may play a 
role of salt-sensitive hypertension.
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Men Women Total
Number 1,048 1,775 2,823
Age, year 59.0 ± 10.6 56.7 ± 10.6 57.5 ± 10.7
Systolic blood pressure, mmHg 134.6 ± 16.4 130.9 ± 16.8 132.3 ± 16.8
Diastolic blood pressure, mmHg 80.9 ± 10.2 77.0 ± 10.1 78.4 ± 10.3
Use of antihypertensive medication, % 23 22 22
Hypertension, %† 48 38 42
Body mass index, kg/m2 23.9 ± 3.0 23.5 ± 3.3 23.6 ± 3.2
Alcohol intake, g/day 21.1 ± 25.2 1.6 ± 6.6 8.8 ± 18.7
24h urine collection, n 720 1,200 1,920
Urine sodium excretion, mmol 205 ± 75 179 ± 66 189 ± 70
Present sodium questionnaire completed, n 1,038 1,764 2,802
Present sodium intake score 5.7 ± 1.9 4.6 ± 1.9 5.0 ± 1.9
Past sodium questionnaire completed, n 1,031 1,761 2,792
Past sodium intake score 6.8 ± 1.8 5.9 ± 2.0 6.3 ± 2.0
Table 1. Clinical and laboratory characteristics (mean, standard deviation and 
proportion), men and women aged 30-74 years.
†Hypertension was defined as systolic blood pressure of ≥ 140 mmHg and/or diastolic 
blood pressure, of ≥ 90 mmHg and/or use of antihypertensive medication.
Table
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DD ID II DD ID II DD ID II
Number 123 473 452 225 809 741 348 1,282 1,193
Age, year 59.6 59.0 58.8 57.8 56.4 56.6 58.5 57.4 57.4
Systolic blood pressure, mmHg 135.1 (1.4)135.4 (0.7)133.6 (0.7) 130.0 (1.0)131.3 (0.5)130.8 (0.6) 131.9 (0.8)132.8 (0.4)131.8 (0.5)
Diastolic blood pressure, mmHg 79.6 (0.9) 81.2 (0.5) 80.9 (0.5) 76.5 (0.7) 77.2 (0.4) 76.9 (0.4) 77.6 (0.6) 78.6 (0.3) 78.4 (0.3)
Use of antihypertensive medication, % 27 22 24 21 23 20 23 22 22
Hypertension, %† 48 50 45 37 39 38 41 43 41
Body mass index, kg/m2 23.8 (0.3) 24.0 (0.1) 23.9 (0.1) 23.6 (0.2) 23.4 (0.1) 23.5 (0.1) 23.7 (0.2) 23.6 (0.1) 23.6 (0.1)
Alcohol intake, g/day 16.7 (2.3) 22.4 (1.2) 21.0 (1.2) 1.9 (0.4) 1.7 (0.2) 1.4 (0.2) 7.1 (1.0) 9.3 (0.5) 8.8 (0.5)
24h urine collection (n) 84 319 317 158 543 499 242 862 816
Urine sodium excretion (mmol) 205 (8) 203 (4) 207 (4) 181 (5) 178 (3) 179 (3) 189 (5) 187 (2) 190 (2)
Present sodium questionnaire completed (n)123 468 447 223 805 736 346 1,273 1,183
Present sodium intake score 5.8 (0.2) 5.7 (0.1) 5.7 (0.1) 4.4 (0.1) 4.7 (0.1) 4.7 (0.1) 4.9 (0.1) 5.0 (0.1) 5.0 (0.1)
Past sodium questionnaire completed (n) 123 464 444 223 802 736 346 1,266 1,180
Past sodium intake score 6.8 (0.2) 6.8 (0.1) 6.9 (0.1) 5.7 (0.1) 6.0 (0.1) 5.9 (0.1) 6.1 (0.1) 6.3 (0.1) 6.3 (0.1)
No statistical significance were observed for age-adjusted means or proportions of characteristics according to genotype using Tukey's multiple 
comparison methods.
†Hypertension was defined as systolic blood pressure of ≥ 140 mmHg and/or diastolic blood pressure, of ≥ 90 mmHg and/or use of 
antihypertensive medication.
Total
Table 2. Age-adjusted means (standard errors) and proportions of characteristics according to angiotensin-I converting enzyme I/D 





p for difference 
of DD vs II DD ID II
p for difference 
of DD vs II DD ID II
p for difference 
of DD vs II
Total 123 473 452 225 809 741 348 1282 1193
  Systolic blood pressure, mmHg 135.4 (1.4) 135.3 (0.7) 133.6 (0.7) 0.36 129.9 (1.0) 131.2 (0.5) 130.8 (0.5) 0.56 131.9 (0.8) 132.7 (0.4) 131.9 (0.4) 1.00
  Diastolic blood pressure, mmHg 79.8 (0.9) 81.1 (0.5) 80.9 (0.5) 0.38 76.3 (0.6) 77.2 (0.3) 76.9 (0.4) 0.64 77.6 (0.5) 78.6 (0.3) 78.4 (0.3) 0.32
Stratified by urinary sodium excretion
below median 39 169 152 77 270 253 116 439 405
  Systolic blood pressure, mmHg 135.6 (2.6) 137.5 (1.2) 134.6 (1.3) 0.89 132.0 (1.7) 133.4 (0.9) 132.3 (1.0) 0.98 133.2 (1.5) 134.9 (0.7) 133.2 (0.8) 1.00
  Diastolic blood pressure, mmHg 81.4 (1.6) 81.5 (0.8) 80.5 (0.8) 0.78 77.5 (1.1) 78.3 (0.6) 76.4 (0.6) 0.56 78.9 (0.9) 79.5 (0.5) 78.0 (0.5) 0.56
beyond median 45 150 165 81 273 246 126 423 411
  Systolic blood pressure, mmHg 136.5 (2.1) 134.5 (1.2) 133.7 (1.1) 0.36 127.4 (1.6) 130.9 (0.8) 129.6 (0.9) 0.32 130.8 (1.2) 132.3 (0.7) 131.1 (0.7) 0.96
  Diastolic blood pressure, mmHg 79.0 (1.4) 80.0 (0.8) 81.1 (0.7) 0.25 74.1 (1.1) 78.2 (0.6) 77.5 (0.6) 0.009 75.9 (0.8) 78.9 (0.5) 78.9 (0.5) 0.003
Stratified by present sodium intake score
below median 53 205 191 114 378 343 167 583 534
  Systolic blood pressure, mmHg 139.7 (2.1) 136.9 (1.0) 136.4 (1.1) 0.24 131.8 (1.4) 132.5 (0.8) 131.9 (0.8) 1.00 134.5 (1.2) 134.0 (0.6) 133.5 (0.6) 0.58
  Diastolic blood pressure, mmHg 81.1 (1.4) 82.4 (0.7) 81.9 (0.7) 0.77 78.0 (0.9) 77.7 (0.5) 77.0 (0.5) 0.50 79.2 (0.8) 79.3 (0.4) 78.8 (0.4) 0.82
beyond median 70 263 256 109 427 393 179 690 649
  Systolic blood pressure, mmHg 132.1 (1.8) 134.1 (0.9) 131.3 (0.9) 0.85 128.0 (1.4) 130.0 (0.7) 130.0 (0.7) 0.31 129.7 (1.1) 131.6 (0.6) 130.5 (0.6) 0.65
  Diastolic blood pressure, mmHg 79.0 (1.2) 80.0 (0.6) 80.3 (0.6) 0.46 74.7 (0.9) 76.7 (0.4) 76.8 (0.5) 0.054 76.3 (0.7) 78.0 (0.4) 78.1 (0.4) 0.04
Stratified by past sodium intake score
below median 49 190 183 98 320 303 147 510 486
  Systolic blood pressure, mmHg 137.2 (2.2) 135.2 (1.1) 135.2 (1.1) 0.59 129.9 (1.5) 130.4 (0.8) 130.3 (0.8) 0.94 132.5 (1.2) 132.2 (0.7) 132.1 (0.7) 0.93
  Diastolic blood pressure, mmHg 81.3 (1.4) 82.2 (0.7) 81.7 (0.7) 0.94 77.3 (1.0) 76.9 (0.6) 76.3 (0.6) 0.55 78.8 (0.8) 78.8 (0.4) 78.3 (0.4) 0.78
beyond median 74 274 261 125 482 433 199 756 694
  Systolic blood pressure, mmHg 134.0 (1.7) 135.2 (0.9) 132.5 (0.9) 0.58 130.2 (1.3) 131.7 (0.7) 131.2 (0.7) 0.68 131.6 (1.0) 133.0 (0.5) 131.7 (0.6) 1.00
  Diastolic blood pressure, mmHg 78.8 (1.2) 80.2 (0.6) 80.4 (0.6) 0.34 75.8 (0.8) 77.3 (0.4) 77.4 (0.5) 0.14 76.8 (0.7) 78.4 (0.4) 78.5 (0.4) 0.06
Blood pressures were adjusted for sex, age, antihypertensive medication use, body mass index and alcohol intake, and for the analysis stratified by urinary sodium excretion, survey years of 
24-hour urine collection. Tests for difference from DD genotype were conducted using Dunnett's multiple comparison method. Medians are 195.7 mmol/day for urinary sodium excretion in 
men and 171.2 mmol/day in women, 5 for present sodium intake score in women and 6 in men, 6 for past sodium intake score in women, and 7 in men..
Table 3. Multivariate-adjusted blood pressure levels (standard errors) according to angiotensin-I converting enzyme I/D genotypes, stratified by sodium 
excretion/intake, men and women ages 30-74 years.
Men Women Total
Table
